#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dupuytren's contracture Immune-mediated myasthenia gravis Thalassaemia Small cell lung cancer Desmoplastic small round cell tumour Central nervous system lymphoma Follicular lymphoma stage I Leukocyte adhesion deficiency type I Anti-myelin-associated glycoprotein associated polyneuropathy Waldenstrom's macroglobulinaemia refractory Neuromyelitis optica spectrum disorder Peritoneal neoplasm Lymphangioma Neuroblastoma Glioma More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Diagnostics Hairy cell leukaemia – Trials in Disease Mucopolysaccharidosis II – Basic Information Idiopathic pulmonary fibrosis – Trials in Disease Haemolytic uraemic syndrome – Trials in Disease Haemophagocytic lymphohistiocytosis – Treatment Mantle cell lymphoma stage III – Basic Information Glomerulonephritis membranoproliferative Testicular leiomyosarcoma – Trials in Disease Encephalitis autoimmune More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tigulixostat Navtemadlin Alnus Glutinosa Pollen L-Lysine Hydrochloride Glycopyrronium Bromide Anhydrous Cyclophosphamide Itraconazole L-Tryptophan ETX-19477 Mbs2320 Leflunomide 99MTC-EUK-(SO3)CY5-MAS3 Obexelimab Riliprubart Valoctocogene Roxaparvovec Paclitaxel Obaluronate Pemetrexed Disodium GSKVX000000030918 TETANUS TOXOID Ciprofloxacin Hydrochloride More therapies…

    Learn about Your Condition

    Inner ear disorder Chronic hepatitis C Peripheral artery restenosis HER2 protein overexpression Post-acute COVID-19 syndrome Ovarian granulosa cell tumour Renal cancer stage IV Glomerulonephritis Ewing's sarcoma recurrent Noninfective chorioretinitis Dyskinesia Loeys-Dietz syndrome Metastases to meninges Electrocorticogram Amyotrophic lateral sclerosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Amyotrophic lateral sclerosis gene carrier

  • Study of Tofersen for Adults with Presymptomatic Amyotrophic Lateral Sclerosis (ALS) Due to SOD1 Gene Mutation

    Not recruiting

    3 1
    Investigated Drugs:
    • Tofersen
    France Germany Italy Poland Spain Sweden

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!